Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 25 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 10562843

    Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  2. US 10562960

    Neutralizing antibodies to gp120 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  3. US 10561722

    Methods and compositions for enhancing immune responses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  4. US 10561724

    Live attenuated virus vaccines for La Crosse virus and other bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  5. US 10561721

    Methods and compositions for inducing protective immunity against filovirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  6. US 10561673

    Dendrimer based nanodevices for therapeutic and imaging purposes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  7. US 10561729

    Near-IR light-cleavable conjugates and conjugate precursors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  8. US 10561666

    Amido compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  9. US 10562952

    Anti-CD276 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  10. US 10556001

    Thermal inactivation of rotavirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  11. US 10556916

    Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  12. US 10557118

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  13. US 10556940

    T cell receptors recognizing HLA-Cw8 restricted mutated KRAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  14. US 10555942

    Emetine compounds for treatment and prevention of flavivirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  15. US 10550164

    Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  16. US 10548987

    Antibody-drug conjugates for targeting CD56-positive tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  17. US 10548970

    Human rotavirus G9P[6] strain and use as a vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  18. US 10543257

    Lentiviral vector for treating hemoglobin disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  19. US 10544392

    Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  20. US 10544406

    Characterization of four prophage endolysins specific for clostridium perfringens

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  21. US 10544085

    Oils having antibacterial activity

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  22. US 10543268

    Genetically engineered swine influenza virus and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  23. US 10538749

    Mutant OPAA enzymes with increased catalytic efficiency on cyclosarin

    The United States of America as represented by the Secretary of the Army · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  24. US 10538590

    Photosensitizing antibody-fluorophore conjugates

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.